Study | Reason for exclusion |
---|---|
Abu Hashim 2013 | Participants had pathology ‒ endometrial hyperplasia |
Adiguzel 2017 | This is not an RCT. Women were offered the different treatments and were free to choose their option |
Apter 2016 | The comparison was relevant LNG‐IUS versus Etonorgestrel implant, participants needed contraception and did not have heavy menstrual bleeding |
Buyuktuna 2016 | This is not an RCT |
Cameron 1987 | The intrauterine system used in this trial has been off the market since 2001 |
Ghazizadeh 2011 | Although the study was described as random, the authors stated that participants were allowed to choose their treatment |
Gupta 2006 | Relevant comparison but participants were able to choose their treatment and were not randomised |
Janssen 1999 | This randomised double‐blind trial compared the effects of a multiload intrauterine device releasing 0.0 (control group), 1.5, 3.0 and 6.0 µg of 3‐ketodesogestrel daily on menstrual blood loss but 22% of the participants did not have heavy menstrual bleeding |
Karacaoglu 2001 | This study was written in Turkish and translated by Dr Ahmet Metin Gulmezoglu. There is no indication that it was randomised |
Karimi‐Zarchi 2013 | Participants had pathology ‒ endometrial hyperplasia |
Kucuk 2008 | Quasi‐randomised trial ‒ "by a predefined application order" |
Lahteenmaki 1998 | This study did not measure any of the review's outcomes |
Lee 2013 | Observational cohort study ‒ participants were not randomised |
Mawet 2014 | The comparison is between two different brands of the same product (LNG‐IUS 20 µg daily) |
McMillan 1998 | Unknown characteristics of study |
McMillan 2005 | Unknown characteristics of study |
Milsom 1991 | This study compared flurbiprofen (an NSAID), tranexamic acid and LNG‐IUS in 35 women with menorrhagia. The first 20 consecutive women were treated with LNG‐IUS and the remaining 15 women were randomised to either flurbiprofen or tranexamic acid in a cross‐over design. The reduction in menstrual blood loss was compared between all treatments. There was no randomization |
Rogerson 1999 | This trial experienced difficulties in recruiting patients and was stopped |
Romer 2000 | This study was a controlled comparative study with equal numbers of patients in each group, endometrial ablation and LNG‐IUS. There is no indication that it was randomised |
Tosun 2014 | Substantially biased study with large imbalance in dropouts, so final results not informative |
LNG‐IUS: levonorgestrel‐releasing intrauterine system NSAID: non‐steroidal anti‐inflammatory drug